Literature DB >> 7635854

Predictors of drug treatment response in obsessive-compulsive disorder.

L Ravizza1, G Barzega, S Bellino, F Bogetto, G Maina.   

Abstract

BACKGROUND: Although a large body of evidence indicates the efficacy of pharmacotherapy in the treatment of obsessive-compulsive disorder (OCD), a considerable percentage of these patients do not respond. Very few studies focus on factors related to treatment response of OCD. The purpose of this study was to investigate which clinical factors are related to drug treatment response in OCD.
METHOD: We examined 53 OCD patients treated with either clomipramine or fluoxetine for a period of 6 months, dividing the sample into "responders" and "nonresponders" to treatment. At admission, patients were evaluated using a semistructured clinical interview, the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), the Hamilton Rating Scale for Depression, and the Hamilton Rating Scale for Anxiety. We then compared acute-phase patient characteristics and response to drug treatment. Response was defined as a decrease of at least 40% in the Y-BOCS total score and a rating of "improved" or "very improved" on the Clinical Global Impressions scale within 16 weeks of treatment and maintained over three consecutive evaluations.
RESULTS: By the sixth month of treatment, 31 patients (58.5%) responded to either clomipramine or fluoxetine. Nonresponders had lower age at onset and longer duration of the disorder; in addition, they showed higher frequency of compulsions, washing rituals, chronic course, concomitant schizotypal personality disorder, and previous hospitalizations. A worse response to drug treatment was predicted in a stepwise multiple regression by (1) concomitant schizotypal personality disorder, (2) presence of compulsions, and (3) longer illness length.
CONCLUSION: Our findings suggest that there are distinct types of OCD with respect to drug treatment response. They provide indirect evidence of treatment specificity by identifying characteristics responsive to different modalities, which may be of value in the selection of patients for alternative treatments.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7635854

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  19 in total

Review 1.  Obsessive compulsive disorder.

Authors:  G Mustafa Soomro
Journal:  BMJ Clin Evid       Date:  2012-01-18

2.  Prediction of remission in obsessive compulsive disorder using a novel machine learning strategy.

Authors:  Kathleen D Askland; Sarah Garnaat; Nicholas J Sibrava; Christina L Boisseau; David Strong; Maria Mancebo; Benjamin Greenberg; Steve Rasmussen; Jane Eisen
Journal:  Int J Methods Psychiatr Res       Date:  2015-05-21       Impact factor: 4.035

Review 3.  Excluding the typical patient: thirty years of pharmacotherapy efficacy trials for obsessive-compulsive disorder.

Authors:  Brian L Odlaug; Eric Weinhandl; Maria C Mancebo; Erik L Mortensen; Jane L Eisen; Steven A Rasmussen; Liana R N Schreiber; Jon E Grant
Journal:  Ann Clin Psychiatry       Date:  2014-02       Impact factor: 1.567

4.  Intensive residential treatment for severe obsessive-compulsive disorder: characterizing treatment course and predictors of response.

Authors:  Brian P Brennan; Catherine Lee; Jason A Elias; Jesse M Crosby; Brittany M Mathes; Marie-Christine Andre; Christina M Gironda; Harrison G Pope; Michael A Jenike; Garrett M Fitzmaurice; James I Hudson
Journal:  J Psychiatr Res       Date:  2014-05-23       Impact factor: 4.791

5.  Obsessive-compulsive disorder for ICD-11: proposed changes to the diagnostic guidelines and specifiers.

Authors:  Helen Blair Simpson; Y C Janardhan Reddy
Journal:  Braz J Psychiatry       Date:  2014       Impact factor: 2.697

6.  A 2-year prospective follow-up study of the course of obsessive-compulsive disorder.

Authors:  Jane L Eisen; Anthony Pinto; Maria C Mancebo; Ingrid R Dyck; Maria E Orlando; Steven A Rasmussen
Journal:  J Clin Psychiatry       Date:  2010-08       Impact factor: 4.384

7.  Are trauma and dissociation related to treatment resistance in patients with obsessive-compulsive disorder?

Authors:  Umit B Semiz; Leman Inanc; Cigdem H Bezgin
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-11-09       Impact factor: 4.328

Review 8.  Obsessive-compulsive disorder.

Authors:  Dan J Stein; Daniel L C Costa; Christine Lochner; Euripedes C Miguel; Y C Janardhan Reddy; Roseli G Shavitt; Odile A van den Heuvel; H Blair Simpson
Journal:  Nat Rev Dis Primers       Date:  2019-08-01       Impact factor: 52.329

9.  A 5-year course of predominantly obsessive vs. mixed subtypes of obsessive-compulsive disorder.

Authors:  S B Math; Jaideep Thoduguli; Y C Janardhan Reddy; P N Manoj; A Zutshi; R P Rajkumar; A M Adarsh
Journal:  Indian J Psychiatry       Date:  2007-10       Impact factor: 1.759

10.  An Atypical and Resistant Case of Obsessive Compulsive Disorder Responding Satisfactorily with an Unusual way of Exposure and Response Prevention Therapy.

Authors:  Kamal Nath; Robin Victor; Subrata Naskar
Journal:  J Clin Diagn Res       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.